title: Worse renal disease in postmenopausal F2[Dahl S x R]-intercross rats: detection of novel QTLs affecting hypertensive kidney disease.
abstract: The prevalence of hypertension increases after menopause with 75% of postmenopausal women developing hypertension in the United States, along with hypertensive end organ diseases. While human and animal model studies have indicated a protective role for estrogen against cardiovascular disease and glomerulosclerosis, clinical studies of hormone replacement therapy in postmenopausal women have shown polar results with some improvement in hypertension but worsening of hypertensive kidney disease, or no effect at all. These observations suggest that the pathogenesis of postmenopausal hypertension and its target organ complications is more complex than projected, and that loss of endogenous estrogens induces epigenetic changes that alter genetic susceptibility to end-organ complications per se resulting in pathogenetic mechanisms beyond correction by hormone replacement. We studied postmenopausal-induced changes in renal disease and performed a total genome scan for quantitative trait loci (QTLs) affecting kidney disease in postmenopausal 16m-old F2[Dahl S x R]-intercross female rats. We used glomerular injury score (GIS) as quantitative trait. We compared QTLs amongst premenopausal, ovariectomized and postmenopausal F2[Dahl S x R]-intercross rats using identical phenotype characterization. Postmenopausal F2[Dahl S x R]-intercross rats exhibited increased hypertensive glomerulosclerosis (P<0.01) and equivalent levels of kidney disease when compared to premenopausal and ovariectomized F2[Dahl S x R]-intercross rats respectively. We detected three significant to highly significant GIS-QTLs (GIS-pm1 on chromosome 4, LOD 3.54; GIS-pm2 on chromosome 3, LOD 2.72; GIS-pm3 on chromosome 5, LOD 2.37) and two suggestive GIS-QTLs (GIS-pm4 on chromosome 2, LOD 1.70; GIS-pm5 on chromosome 7, LOD 1.28), all of which were unique to this postmenopausal population. Detection of increased renal disease phenotype in postmenopausal and ovariectomized subjects suggests a protective role of ovarian hormones. Furthermore, the detection of distinct GIS-QTLs in postmenopausal intercross female rats suggests that distinct genetic mechanisms underlie hypertensive glomerulosclerosis in premenopausal and postmenopausal states.
authors: Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
authors: Victoria L M
authors: VL
authors: Herrera
authors: Khristine A
authors: KA
authors: Pasion
authors: Ann Marie
authors: AM
authors: Moran
authors: Nelson
authors: N
authors: Ruiz-Opazo
mesh_terms: D000818:Animals; D003433:Crosses, Genetic; D005260:Female; D006977:Hypertension, Renal / Q000235:genetics*; D007674:Kidney Diseases / Q000235:genetics*; D017698:Postmenopause; D040641:Quantitative Trait Loci / Q000235:genetics*; D051381:Rats; D020303:Rats, Inbred Dahl
references: Am J Physiol Renal Physiol. 2008 Dec;295(6):F1764-77
references: 18842817
references: BMJ. 2004 May 8;328(7448):1105
references: 15096438
references: Nephrol Dial Transplant. 2003 Oct;18(10):2047-53
references: 13679479
references: Regul Pept. 2008 Jan 10;145(1-3):24-32
references: 17935800
references: Kidney Int. 2008 Aug;74(3):370-6
references: 18496507
references: Blood. 2006 Jan 15;107(2):661-8
references: 16204306
references: Mamm Genome. 2001 Dec;12(12):930-2
references: 11707780
references: Kidney Int. 2006 Jun;69(12):2155-61
references: 16531986
references: Physiol Genomics. 2003 Nov 11;15(3):243-57
references: 14532335
references: Physiol Genomics. 2006 Aug 16;26(3):172-9
references: 16720678
references: Transplant Proc. 2011 May;43(4):1297-9
references: 21620115
references: Hypertens Res. 2012 Feb;35(2):148-52
references: 22129517
references: Arch Intern Med. 2001 Sep 10;161(16):2000-5
references: 11525702
references: Gend Med. 2008 Jun;5(2):147-59
references: 18573482
references: Exp Biol Med (Maywood). 2006 Jun;231(6):997-1000
references: 16741037
references: Hypertension. 2006 Jun;47(6):1168-74
references: 16618835
references: Kidney Int. 1997 Mar;51(3):850-4
references: 9067920
references: Hypertension. 2003 Mar;41(3 Pt 2):640-5
references: 12623972
references: Hypertension. 1996 Aug;28(2):196-201
references: 8707381
references: Curr Opin Nephrol Hypertens. 2010 Sep;19(5):499-504
references: 20689424
references: Menopause. 2011 Jun;18(6):629-37
references: 21326121
references: J Mol Neurosci. 2008 Nov;36(1-3):89-96
references: 18478450
references: J Clin Invest. 1998 Sep 15;102(6):1102-11
references: 9739044
references: Biol Reprod. 1988 May;38(4):780-9
references: 3401536
references: PLoS One. 2012;7(8):e43160
references: 22912817
references: Am J Hypertens. 2004 Oct;17(10):994-1001
references: 15485766
references: Am J Kidney Dis. 2012 Jan;59(1 Suppl 1):A7, e1-420
references: 22177944
references: Circulation. 2007 Feb 6;115(5):e69-171
references: 17194875
references: Kidney Int. 1984 Aug;26(2):137-43
references: 6239058
references: J Am Soc Nephrol. 2000 Feb;11(2):319-329
references: 10665939
references: J Hypertens. 2012 Aug;30(8):1572-80
references: 22688265
references: BJOG. 2000 Aug;107(8):1017-21
references: 10955435
references: Am J Kidney Dis. 2005 Jun;45(6):1019-25
references: 15957130